- Home
- PMTS vs GNFT Comparison
PMTS vs GNFT Comparison
Compare PMTS & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMTS
- GNFT
- Stock Information
- Founded
- PMTS 2007
- GNFT 1999
- Country
- PMTS United States
- GNFT France
- Employees
- PMTS N/A
- GNFT N/A
- Industry
- PMTS Finance Companies
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PMTS Finance
- GNFT Health Care
- Exchange
- PMTS Nasdaq
- GNFT Nasdaq
- Market Cap
- PMTS 332.0M
- GNFT 296.4M
- IPO Year
- PMTS 2015
- GNFT 2019
- Fundamental
- Price
- PMTS $35.04
- GNFT $3.79
- Analyst Decision
- PMTS Strong Buy
- GNFT Strong Buy
- Analyst Count
- PMTS 4
- GNFT 1
- Target Price
- PMTS $34.00
- GNFT $13.00
- AVG Volume (30 Days)
- PMTS 43.2K
- GNFT 6.6K
- Earning Date
- PMTS 11-05-2024
- GNFT 09-19-2024
- Dividend Yield
- PMTS N/A
- GNFT N/A
- EPS Growth
- PMTS N/A
- GNFT N/A
- EPS
- PMTS 1.30
- GNFT 0.47
- Revenue
- PMTS $458,377,000.00
- GNFT $86,225,222.00
- Revenue This Year
- PMTS $9.16
- GNFT $155.44
- Revenue Next Year
- PMTS $7.71
- GNFT N/A
- P/E Ratio
- PMTS $26.43
- GNFT $7.85
- Revenue Growth
- PMTS N/A
- GNFT 175.45
- 52 Week Low
- PMTS $15.00
- GNFT $3.31
- 52 Week High
- PMTS $34.90
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- PMTS 69.64
- GNFT 26.93
- Support Level
- PMTS $33.19
- GNFT $3.63
- Resistance Level
- PMTS $34.90
- GNFT $3.85
- Average True Range (ATR)
- PMTS 1.33
- GNFT 0.12
- MACD
- PMTS -0.06
- GNFT 0.01
- Stochastic Oscillator
- PMTS 80.82
- GNFT 11.88
About PMTS CPI Card Group Inc.
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.